Shares of Health Care sector company West Pharmaceutical Services moved -30.7% today, and are now trading at a price of $223.28. The Large-Cap stock's daily volume was 789,582 compared to its average volume of 487,765. The S&P 500 index returned a 0.0% performance.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company is based in Exton and has 10,600 full time employees. Its market capitalization is $16,170,473,472. West Pharmaceutical Services currently offers its equity investors a dividend that yields 0.2% per year.
Over the last year, WST shares have gone down by -8.1%, which represents a difference of -28.4% when compared to the S&P 500. The stock's 52 week high is $400.88 per share and its 52 week low is $221.01. With average free cash flows of $317.88 Million that have been growing at an average rate of 14.3% over the last 5 years, West Pharmaceutical Services declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 776,500 | 362,000 | 414,500 | -5.67 |
| 2022 | 724,000 | 284,600 | 439,400 | 32.91 |
| 2021 | 584,000 | 253,400 | 330,600 | 10.9 |
| 2020 | 472,500 | 174,400 | 298,100 | 23.8 |
| 2019 | 367,200 | 126,400 | 240,800 | 30.94 |
| 2018 | 288,600 | 104,700 | 183,900 |
